Holly Springs, North Carolina — According to state and local development sources, Amgen plans to invest $1 Billion to expand in Holly Springs. The company is creating 370 new jobs at this facility. The company plans to occupy the new space in Holly Springs, on or about November 1, 2027. According to the company website Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world’s toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the World’s Most Innovative Companies by Fast Company and one of America’s Best Large Employers by Forbes, among other external recognitions. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average, and it is also part of the Nasdaq-100 Index, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.

To learn more about Amgen, visit http://www.amgen.com/

Company Contact:
Robert Bradway, Chief Executive Officer
rbradway@amgen.com
https://www.linkedin.com/in/bob-bradway/
805-447-1000

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.